CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY side effect
What is CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY ?Drugs associated with CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY
ABILIFY CLARAVIS DEPAKENE DEPAS ESCITALOPRAM INFLAMMIDE IRBESARTAN KEPPRA LAMICTAL LOVENOX PAROXETINE STRATTERA VALACYCLOVIRCONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Lovenox Side Effects Report #5670572-8
Consumer or non-health professional from UNITED STATES reported LOVENOX problem on Mar 11, 2008. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, multiple congenital abnormalities, . LOVENOX dosage: unknown. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Depakene Side Effects Report #5646118-7
DEPAKENE problem was reported by a Consumer or non-health professional from FRANCE on Feb 20, 2008. Female patient was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, congenital cerebellar agenesis, congenital cerebrovascular anomaly, congenital musculoskeletal anomaly, . DEPAKENE dosage: unknown. During the same period patient was treated with TOPIRAMATE. Patient died.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Claravis Side Effects Report #5538363-6
Physician from UNITED STATES reported CLARAVIS problem on Nov 20, 2007. Male patient was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, congenital choroidal anomaly, congenital hydrocephalus, foetal cardiac disorder, head deformity, low set ears, . CLARAVIS dosage: unknown. Patient died on 10/05/2007.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Lamictal Side Effects Report #5483796-X
LAMICTAL problem was reported by a Consumer or non-health professional from FRANCE on Oct 01, 2007. Male patient was diagnosed with epilepsy and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, talipes, . LAMICTAL dosage: 100MG TWICE PER DAY. During the same period patient was treated with DEPAKENE, GARDAN. Patient was hospitalized. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Claravis Side Effects Report #5450722-9
Physician from UNITED STATES reported CLARAVIS problem on Aug 27, 2007. Female patient was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, congenital choroidal anomaly, heart disease congenital, . CLARAVIS dosage: 40 MG, QD, TRANSPLACENTAL. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Claravis Side Effects Report #5450723-0
CLARAVIS problem was reported by a Physician from UNITED STATES on Sept 05, 2007. Female patient, 15 years of age, was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, heart disease congenital, neural tube defect, treatment noncompliance, ultrasound antenatal screen abnormal, unintended pregnancy, . CLARAVIS dosage: 40 MG, QD, ORAL. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Valacyclovir Side Effects Report #5468197-2
Consumer or non-health professional from FRANCE reported VALACYCLOVIR problem on Sept 10, 2007. Female patient was diagnosed with cytomegalovirus infection and was treated with VALACYCLOVIR. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, foetal disorder, premature baby, splenomegaly, . VALACYCLOVIR dosage: unknown. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Irbesartan Side Effects Report #5409408-9
IRBESARTAN problem was reported by a Health Professional from on Aug 07, 2007. Female patient, 24 years of age, was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, pregnancy, renal aplasia, . IRBESARTAN dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, CALCIUM SUPPLEMENT, IRON SUPPLEMENT, EPOGEN, LEVOTHYROXINE, INSULIN. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Inflammide Side Effects Report #5385109-0
Consumer or non-health professional from UNITED STATES reported INFLAMMIDE problem on July 06, 2007. Female patient, weighting 7.05 lb, was diagnosed with asthma and was treated with INFLAMMIDE. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, developmental delay, hypotonia, . INFLAMMIDE dosage: unknown. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Inflammide Side Effects Report #5385109-0
INFLAMMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Female patient, weighting 7.05 lb, was diagnosed with asthma and was treated with INFLAMMIDE. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly, developmental delay, hypotonia, . INFLAMMIDE dosage: unknown. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Strattera Side Effects Report #5649883-8
Physician from UNITED STATES reported STRATTERA problem on Feb 20, 2008. Male patient, weighting 74.99 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: adenotonsillectomy, congenital central nervous system anomaly, convulsion, electroencephalogram abnormal, hallucination, auditory, hallucination, visual, . STRATTERA dosage: 35 MG, EACH EVENING. During the same period patient was treated with CONCERTA. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Keppra Side Effects Report #5623878-2
KEPPRA problem was reported by a Physician from FRANCE on Jan 23, 2008. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: cerebral ventricle dilatation, congenital central nervous system anomaly, . KEPPRA dosage: 1500 MG 1/D TRP. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Depakene Side Effects Report #5645725-5
Health Professional from FRANCE reported DEPAKENE problem on Feb 22, 2008. Female patient was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: caesarean section, congenital central nervous system anomaly, hypertelorism of orbit, neonatal aspiration, polyhydramnios, premature baby, septum pellucidum agenesis, thrombocytopenia neonatal, . DEPAKENE dosage: unknown. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Escitalopram Side Effects Report #5648540-1
ESCITALOPRAM problem was reported by a Health Professional from PORTUGAL on Feb 14, 2008. Female patient was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital central nervous system anomaly, . ESCITALOPRAM dosage: 10 MG QD TRANSPLACENTAL. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Paroxetine Side Effects Report #5522052-8
Health Professional from UNITED STATES reported PAROXETINE problem on Nov 01, 2007. Female patient was treated with PAROXETINE. After drug was administered, patient experienced the following problems/side effects: cerebellar hypoplasia, congenital central nervous system anomaly, . PAROXETINE dosage: unknown. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Abilify Side Effects Report #5471118-X
ABILIFY problem was reported by a Physician from FRANCE on Sept 24, 2007. Female patient, 42 years of age, weighting 154.3 lb, was diagnosed with schizophrenia, hypothyroidism and was treated with ABILIFY. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital central nervous system anomaly, pregnancy, . ABILIFY dosage: unknown. During the same period patient was treated with XANAX, LEVOTHYROX. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Irbesartan Side Effects Report #5411009-3
Health Professional from SPAIN reported IRBESARTAN problem on Aug 07, 2007. Female patient, 24 years of age, weighting 134.5 lb, was diagnosed with hypertension and was treated with IRBESARTAN. After drug was administered, patient experienced the following problems/side effects: abortion induced, congenital central nervous system anomaly, pregnancy, renal aplasia, . IRBESARTAN dosage: unknown. During the same period patient was treated with INSULIN GLARGINE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Keppra Side Effects Report #5625923-7
KEPPRA problem was reported by a Physician from FRANCE on Jan 24, 2008. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: brain malformation, cerebral ventricle dilatation, congenital central nervous system anomaly, foetal malformation, . KEPPRA dosage: 1500 MG 1/D TRP. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Lamictal Side Effects Report #5529368-X
Consumer or non-health professional from UNITED STATES reported LAMICTAL problem on Nov 20, 2007. Female patient, weighting 6.83 lb, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: brain malformation, cerebral ventricle dilatation, congenital central nervous system anomaly, developmental delay, hydrocephalus, . LAMICTAL dosage: unknown. During the same period patient was treated with KLONOPIN, PROZAC, XANAX, ATIVAN. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Depas Side Effects Report #5476574-9
DEPAS problem was reported by a Health Professional from JAPAN on Sept 27, 2007. Male patient, weighting 8.40 lb, was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia, . DEPAS dosage: unknown. During the same period patient was treated with ALPRAZOLAM, LUDIOMIL. Patient was hospitalized. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Claravis Side Effects Report #5495451-0
Physician from UNITED STATES reported CLARAVIS problem on Oct 08, 2007. Male patient was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: apgar score low, congenital anomaly, congenital central nervous system anomaly, congenital choroidal anomaly, head deformity, heart disease congenital, low set ears, . CLARAVIS dosage: 40 MG, QD, TRANSPLACENTAL. Patient died on 10/05/2007.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Depas Side Effects Report #5467785-7
DEPAS problem was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2007. Male patient, weighting 8.38 lb, was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia, . DEPAS dosage: unknown. During the same period patient was treated with ALPRAZOLAM, LUDIOMIL. Patient was hospitalized. Patient recovered.
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY : Valacyclovir Side Effects Report #5468199-6
Consumer or non-health professional from FRANCE reported VALACYCLOVIR problem on Sept 10, 2007. Female patient was diagnosed with cytomegalovirus infection and was treated with VALACYCLOVIR. After drug was administered, patient experienced the following problems/side effects: abortion induced, brain damage, congenital central nervous system anomaly, congenital cerebral cyst, foetal disorder, . VALACYCLOVIR dosage: unknown. Patient recovered.